0001104659-23-119813.txt : 20231120
0001104659-23-119813.hdr.sgml : 20231120
20231120120801
ACCESSION NUMBER: 0001104659-23-119813
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231120
FILED AS OF DATE: 20231120
DATE AS OF CHANGE: 20231120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones Robert B
CENTRAL INDEX KEY: 0001431759
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10113
FILM NUMBER: 231421704
MAIL ADDRESS:
STREET 1: C/O ACURA PHARMACEUTICALS, INC.
STREET 2: 616 N NORTH COURT
CITY: PALATINE
STATE: IL
ZIP: 60067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0000786947
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 110853640
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
CITY: PALATINE
STATE: IL
ZIP: 60067
BUSINESS PHONE: 847-705-7709
MAIL ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
STREET 2: .
CITY: PALATINE
STATE: IL
ZIP: 60067
FORMER COMPANY:
FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW
DATE OF NAME CHANGE: 19920703
4
1
tm2331068-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-11-20
0
0000786947
ACURA PHARMACEUTICALS, INC
ACUR
0001431759
Jones Robert B
C/O ACURA PHARMACEUTICALS, INC.
616 N. NORTH COURT, SUITE 120
PALATINE
IL
60067
0
1
0
0
President & CEO
0
Common Stock
2023-11-20
4
M
0
40000
A
643555
D
Restricted Stock Unit (2021 Plan)
0.01
2023-11-20
4
M
0
40000
D
Common Stock
40000
0
D
Represents exchange of restricted stock units.
Par value of $.01 was paid by Reporting Person upon exchange of Restricted Stock Units for stock.
Not Applicable.
40,000 Restricted Stock Units were granted on March 16, 2022 and were 100% vested on December 31, 2022
/s/ Robert B. Jones
2023-11-20